HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$11.78
Day range
$11.26 - $12.03
Year range
$6.19 - $13.16
Market cap
639.36M USD
Avg Volume
2.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 25.88M | 481.73% |
Operating expense | 25.83M | 4.70% |
Net income | 74.71M | 474.94% |
Net profit margin | 288.66 | 164.45% |
Earnings per share | -0.06 | 87.50% |
EBITDA | -10.68M | 51.97% |
Effective tax rate | 2.86% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 202.61M | 311.33% |
Total assets | 256.28M | 77.47% |
Total liabilities | 139.05M | 24.23% |
Total equity | 117.23M | — |
Shares outstanding | 56.14M | — |
Price to book | 5.53 | — |
Return on assets | -14.37% | — |
Return on capital | -21.83% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 74.71M | 474.94% |
Cash from operations | -3.60M | 81.16% |
Cash from investing | 11.93M | 9,351.16% |
Cash from financing | 1.38M | -90.99% |
Net change in cash | 10.37M | 388.99% |
Free cash flow | -7.92M | 38.72% |
About
Founded
2006
Website
Employees
59
